PURPOSE: To characterize the pharmacokinetics (PK) of oxycodone following intravenous injection and administration of three oral dosage forms (solution, capsule, and controlled-release tablet) in elderly patients (age 76-89 years) undergoing cystoscopy. METHODS: This was an open, randomized study with two sequences and two visits in 15 elderly patients. The patients were given intravenous injection (over 10 min) of 5 mg of oxycodone hydrochloride trihydrate. Oxycodone hydrochloride (5 mg in all forms) was orally administered as a solution, a capsule, and a controlled-release tablet. Venous blood samples were collected up to 17 h after oxycodone administration. Population PK parameters were calculated with NONMEM VI 2.0. For intravenous injection we calculated clearance, volume of distribution at steady state, and the half-life of elimination, and for oral dosage forms also the absolute bioavailability. RESULTS:Clearance of the intravenous injections was 28.9 L/h; the volume of distribution at steady state and the half-life of elimination were 186 L and 5.2 h, respectively. The absolute bioavailability of oxycodone was 59 % from oral solutions, 64 % from capsules, and 55 % from controlled-release tablets. CONCLUSIONS: Our results indicate that, in the elderly, the bioavailability of the three different oral dosage forms of oxycodone is fairly similar.
RCT Entities:
PURPOSE: To characterize the pharmacokinetics (PK) of oxycodone following intravenous injection and administration of three oral dosage forms (solution, capsule, and controlled-release tablet) in elderly patients (age 76-89 years) undergoing cystoscopy. METHODS: This was an open, randomized study with two sequences and two visits in 15 elderly patients. The patients were given intravenous injection (over 10 min) of 5 mg of oxycodone hydrochloride trihydrate. Oxycodone hydrochloride (5 mg in all forms) was orally administered as a solution, a capsule, and a controlled-release tablet. Venous blood samples were collected up to 17 h after oxycodone administration. Population PK parameters were calculated with NONMEM VI 2.0. For intravenous injection we calculated clearance, volume of distribution at steady state, and the half-life of elimination, and for oral dosage forms also the absolute bioavailability. RESULTS: Clearance of the intravenous injections was 28.9 L/h; the volume of distribution at steady state and the half-life of elimination were 186 L and 5.2 h, respectively. The absolute bioavailability of oxycodone was 59 % from oral solutions, 64 % from capsules, and 55 % from controlled-release tablets. CONCLUSIONS: Our results indicate that, in the elderly, the bioavailability of the three different oral dosage forms of oxycodone is fairly similar.
Authors: Gunnar H Gislason; Jeppe N Rasmussen; Steen Z Abildstrom; Tina K Schramm; Morten L Hansen; Emil L Fosbøl; Rikke Sørensen; Fredrik Folke; Pernille Buch; Niels Gadsbøll; Søren Rasmussen; Henrik E Poulsen; Lars Køber; Mette Madsen; Christian Torp-Pedersen Journal: Arch Intern Med Date: 2009-01-26
Authors: Tuija H Nieminen; Nora M Hagelberg; Teijo I Saari; Antti Pertovaara; Mikko Neuvonen; Kari Laine; Pertti J Neuvonen; Klaus T Olkkola Journal: Anesthesiology Date: 2009-06 Impact factor: 7.892
Authors: Rajiv Balyan; Marc Mecoli; Raja Venkatasubramanian; Vidya Chidambaran; Nichole Kamos; Smokey Clay; David L Moore; Jagroop Mavi; Chris D Glover; Peter Szmuk; Alexander Vinks; Senthilkumar Sadhasivam Journal: Pharmacogenomics Date: 2017-02-17 Impact factor: 2.533
Authors: Bruce Charles; Janet Hardy; Helen Anderson; Angela Tapuni; Rani George; Ross Norris Journal: Support Care Cancer Date: 2014-02 Impact factor: 3.603
Authors: Merja Kokki; Moona Kuronen; Toivo Naaranlahti; Timo Nyyssönen; Ira Pikkarainen; Sakari Savolainen; Hannu Kokki Journal: Adv Ther Date: 2016-12-05 Impact factor: 3.845
Authors: Antti Valtola; James D Morse; Pawel Florkiewicz; Heidi Hautajärvi; Pasi Lahtinen; Tadeusz Musialowicz; Brian J Anderson; Veli-Pekka Ranta; Hannu Kokki Journal: J Drug Assess Date: 2020-07-28